MDC — Mediclinic International Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge Cap

Annual income statement for Mediclinic International, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.

	C2018 March 31st	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	2,876	2,932	3,083	2,995	3,233
Cost of Revenue
Gross Profit	1,097	1,105	1,123	—	—
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	3,273	3,015	3,277	2,726	2,953
Operating Profit	-397	-83	-194	269	280
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-479	-137	-275	104	211
Provision for Income Taxes
Net Income After Taxes	-474	-130	-299	79	170
Minority Interest
Net Income Before Extraordinary Items
Net Income	-492	-151	-320	68	151
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-492	-151	-320	68	151
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.005	0.155	0.27	0.023	0.195
Dividends per Share